Terazosin Hydrochloride Anhydrous
- Product NDC
- 71335-0787
- 11-digit product format
- 713350787
- Labeler code
- 71335
- Product ID
- 71335-0787_4a6920b3-17e8-4c74-a859-fddc3c935dd0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin hydrochloride anhydrous
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075140
- Marketing category
- ANDA
- Marketing start
- 2000-02-22
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0787-1 | 71335078701 | 150 CAPSULE in 1 BOTTLE (71335-0787-1) | 150 capsule | 2000-02-22 | 0000-00-00 | No | No | Current |
| 71335-0787-2 | 71335078702 | 30 CAPSULE in 1 BOTTLE (71335-0787-2) | 30 capsule | 2000-02-22 | 0000-00-00 | No | No | Current |
| 71335-0787-3 | 71335078703 | 90 CAPSULE in 1 BOTTLE (71335-0787-3) | 90 capsule | 2000-02-22 | 0000-00-00 | No | No | Current |
| 71335-0787-4 | 71335078704 | 100 CAPSULE in 1 BOTTLE (71335-0787-4) | 100 capsule | 2000-02-22 | 0000-00-00 | No | No | Current |
| 71335-0787-5 | 71335078705 | 28 CAPSULE in 1 BOTTLE (71335-0787-5) | 28 capsule | 2000-02-22 | 0000-00-00 | No | No | Current |
| 71335-0787-6 | 71335078706 | 60 CAPSULE in 1 BOTTLE (71335-0787-6) | 60 capsule | 2018-04-23 | 0000-00-00 | No | No | Current |